ARCHIVES

ONS Membership Still Climbing, Soars over 15,000

This article is from The Cancer Letter archive.

Vol. 15 No. 25 | June 23, 1989

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

DCE Advisors Approve New Epidemiology RFPs Table Proposed RFA

April 16, 1993

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

August 18, 1989

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

January 3, 1992

NCI Advisory Group, other Cancer Meetings

July 29, 1988

NCI relaxes Core Grants Support For Clinical Trials Research

December 11, 1992